# 🔬 Scientifically Valid SDOH Model - Executive Summary

## Methodology Validation

### Proper Data Split Usage (No Data Leakage)
- **Training Set (60%, n=236,235)**: Used exclusively for model fitting
- **Validation Set (20%, n=78,745)**: Used for:
  - Model calibration (Platt scaling)
  - Optimal threshold selection
  - Early stopping during training
- **Test Set (20%, n=78,745)**: Held out completely until final evaluation
  - Never used for any model decisions
  - Provides unbiased performance estimates

### Key Methodological Safeguards
1. ✅ Threshold selected on validation set only (0.0500)
2. ✅ Test set never influenced any modeling decisions
3. ✅ All reported metrics below are from the held-out test set
4. ✅ Calibration performed on validation set, not test set

## Unbiased Test Set Performance

### Overall Model Performance
| Metric | Value | Interpretation |
|--------|-------|----------------|
| **AUC** | 0.7650 | Good discrimination ability |
| **AUPRC** | 0.2110 | 3.2x better than baseline (0.066) |
| **ECE** | 0.0075 ✅ | Excellent calibration (target <0.05) |
| **Brier Score** | 0.0583 | Low prediction error |

### Performance at Validation-Selected Threshold (0.0500)
| Metric | Value | Clinical Impact |
|--------|-------|----------------|
| **Screening Rate** | 34.8% | Manageable workload |
| **Sensitivity** | 72.2% | Captures 7 out of 10 patients with needs |
| **Specificity** | 67.9% | Correctly excludes 2/3 of low-risk patients |
| **PPV** | 13.8% | 2.1x improvement over baseline (6.6%) |
| **NPV** | 97.2% | High confidence in negative predictions |

### Overfitting Assessment
- Validation AUC: 0.7759
- Test AUC: 0.7650
- **Difference: 0.0109** ✅ (No significant overfitting)

## Model Characteristics

### Training Approach
- **Base Model**: XGBoost with balanced parameters
- **Calibration**: Platt scaling (sigmoid calibration)
- **Parameters**: Optimized to avoid overly conservative predictions
  - max_depth: 5
  - scale_pos_weight: 0.8
  - n_estimators: 200

### Key Features (Top 5)
1. Housing/Transportation vulnerability (rpl_theme3)
2. Insurance type indicators
3. Socioeconomic status metrics
4. Healthcare utilization patterns
5. Geographic vulnerability indices

## Clinical Deployment Recommendations

### Immediate Implementation
1. **Use threshold = 0.0500** (scientifically validated)
2. **Expected outcomes per 10,000 patients**:
   - Screen: 3,480 patients
   - Identify: ~480 patients with SDOH needs
   - Miss: ~180 patients with needs (28% false negative rate)

### Monitoring Requirements
1. **Monthly metrics**:
   - Screening rate (target: 30-40%)
   - PPV (should remain >12%)
   - ECE (must stay <0.05)

2. **Quarterly recalibration** if:
   - ECE exceeds 0.05
   - Screening rate falls outside 25-45%
   - PPV drops below 12%

### Resource Adjustment Options
| Resources | Threshold | Screening Rate | Sensitivity | PPV |
|-----------|-----------|----------------|-------------|-----|
| Limited | 0.08 | ~20% | ~55% | ~18% |
| Standard | 0.05 | ~35% | ~72% | ~14% |
| Expanded | 0.04 | ~42% | ~78% | ~12% |

## Key Figures Generated

1. **performance_scientifically_valid.png**
   - ROC curve, PR curve, calibration plot, score distributions
   - Shows excellent model calibration and discrimination

2. **validation_vs_test_comparison.png**
   - Direct comparison of all metrics between validation and test sets
   - Demonstrates no overfitting

## Model Files

- `models/xgboost_scientific_base.json` - Base XGBoost model
- `models/xgboost_scientific_calibrated.joblib` - Calibrated model (ready for deployment)
- `models/scientific_model_metadata.json` - Complete model metadata and parameters

## Executive Summary

This SDOH screening model was developed using scientifically rigorous methodology with proper train/validation/test splits and no data leakage. The model achieves:

1. **Strong performance**: AUC of 0.765 with excellent calibration (ECE = 0.0075)
2. **Clinical utility**: Screens 35% of patients while maintaining 2x better PPV than random screening
3. **Balanced approach**: 72% sensitivity ensures most at-risk patients are identified
4. **Deployment ready**: All metrics are from held-out test data, providing realistic performance expectations

The model is ready for clinical deployment with clear thresholds, monitoring guidelines, and proven performance on unseen data.